Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Forsyth

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Neuro-Oncology|April 17, 2001
Myeloablative chemotherapy for recurrent aggressive oligodendrogliomaG Cairncross, L Swinnen, R Bayer, et al.
Inorganic Chemistry|October 24, 2001
Synthesis and Electrochemical Studies of a Series of Fluorinated DodecaphenylporphyrinsKarl M. Kadish, Eric Van Caemelbecke, Francis D'Souza, et al.
Psychological Assessment|March 21, 2007
Taxometric and factor analytic models of anxiety sensitivity: integrating approaches to latent structural researchAmit Bernstein, Michael J Zvolensky, Peter J Norton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340A Price, Q Shi, D Morris, et al.
British Journal of Cancer|July 5, 2007
The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group studyM Mauer, R Stupp, M J B Taphoorn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trialW Roa, P M A Brasher, G Bauman, et al.
Neurology|September 2, 2011
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastomaM Weller, T Gorlia, J G Cairncross, et al.
Journal of Medicinal Chemistry|May 3, 2012
Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitorsJames W Leahy, Chris A Buhr, Henry W B Johnson, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Neuro-Oncology|April 17, 2001
Myeloablative chemotherapy for recurrent aggressive oligodendrogliomaG Cairncross, L Swinnen, R Bayer, et al.
Inorganic Chemistry|October 24, 2001
Synthesis and Electrochemical Studies of a Series of Fluorinated DodecaphenylporphyrinsKarl M. Kadish, Eric Van Caemelbecke, Francis D'Souza, et al.
Psychological Assessment|March 21, 2007
Taxometric and factor analytic models of anxiety sensitivity: integrating approaches to latent structural researchAmit Bernstein, Michael J Zvolensky, Peter J Norton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340A Price, Q Shi, D Morris, et al.
British Journal of Cancer|July 5, 2007
The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomised phase III EORTC Brain Tumour and Radiation Oncology Groups, and NCIC Clinical Trials Group studyM Mauer, R Stupp, M J B Taphoorn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trialW Roa, P M A Brasher, G Bauman, et al.
Neurology|September 2, 2011
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastomaM Weller, T Gorlia, J G Cairncross, et al.
Journal of Medicinal Chemistry|May 3, 2012
Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitorsJames W Leahy, Chris A Buhr, Henry W B Johnson, et al.
Pageof 14